- Addressing human factors in the recognition and management of local anaesthetic systemic toxicity more
- Addressing older people's mental health needs in the community setting. more
- Addressing Online Harms in Policy – Failing to Learn from the War on Drugs more
- Addressing prescription discrepancies in renal patients: A prospective audit more
- Addressing the Accessibility of Social Media more
- Addressing the Challenges of Situationally-Induced Impairments and Disabilities in Mobile Interaction more
- Addressing the human factor in information systems security more
- Addressing the imbalance of international diabetes care more
- Addressing the inequalities in global genetic studies for the advancement of Genetic Epidemiology more
- Addressing the mental health of nurses during the COVID-19 pandemic: Time for support. more
- Addressing the nation more
- Addressing the Security Gap in IoT: Towards an IoT Cyber Range. more
- Adherence to Community Based Group Exercise Interventions for Older People: A Mixed-Methods Systematic Review more
- Adherence to Community Based Group Exercise Interventions in Older People: A Systematic Review more
- Adherence to Neuromuscular Electrical Stimulation Interventions for Muscle Impairment in Hip and Knee Osteoarthritis: A Systematic Review more
- Adherence to the class-based component of a Tai Chi exercise intervention for people living with dementia and their informal carers more
- Adhesive Threshold Predictive Modelling for Coatings in the Presence of Interfacial Impurity more
- Ad-Hoc, Mobile and Wireless Networks, 9th International Conference, ADHOC-NOW 2010, Edmonton, Alberta, Canada, August 20-22, 2010. Proceedings more
- Ad-hoc, Mobile, and Wireless Networks - 15th International Conference, ADHOC-NOW 2016, Lille, France, July 4-6, 2016, Proceedings more
- Adjunct professors and legal pracademics more
- Adjusting plasma ferritin concentrations to remove the effects of subclinical inflammation in the assessment of iron deficiency: a meta-analysis. more
- Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study more
- Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. more
- Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. more
- Administration of cetuximab in managing colorectal cancer. more